Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-12-13FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Clozapine from Mylan Pharmaceuticals Inc., granting changes to the product labeling under th…
-
FDA approval · 2014-12-10FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
The FDA approved Viatris Specialty LLC's supplemental application for Geodon (ziprasidone mesylate).
-
FDA approval · 2014-12-08FDA Approved: OLANZAPINE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for a generic olanzapine product from Aurobindo Pharma Limited.
-
FDA approval · 2014-12-08FDA Approved: OLANZAPINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for olanzapine submitted by Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2014-12-08FDA Approved: OLANZAPINE — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approves Jubilant Cadista Pharmaceuticals Inc.'s supplemental application for olanzapine, enabling a generic olanzapine product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-11-28FDA Approved: RISPERIDONE — Supplemental Application (Natco Pharma USA LLC)
The FDA approved a supplemental application for risperidone from Natco Pharma USA LLC under an ANDA, enabling continued marketing of a gener…
-
FDA approval · 2014-11-18FDA Approved: SAPHRIS — Supplemental Application (Allergan, Inc.)
The FDA approved Allergan's supplemental application for SAPHRIS (asenapine) to update its labeling, reflecting an expanded or clarified ind…
-
FDA approval · 2014-11-12FDA Approved: INVEGA SUSTENNA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVEGA SUSTENNA (paliperidone palmitate) submitted by Janssen Pharmaceuticals, Inc.
-
FDA approval · 2014-10-30FDA Approved: QUETIAPINE — Supplemental Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare Inc.'s supplemental application for quetiapine, enabling the marketing of a generic quetiapine product. The a…
-
FDA approval · 2014-10-30FDA Approved: ZYPREXA RELPREVV — Supplemental Application (H2-Pharma LLC)
FDA approved a supplemental application for ZYPREXA RELPREVV (olanzapine pamoate) submitted by H2-Pharma LLC, likely resulting in changes to…
-
FDA approval · 2014-10-28FDA Approved: QUETIAPINE FUMARATE — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's original generic application for quetiapine fumarate, a second-generation antipsychotic used …
-
FDA approval · 2014-10-21FDA Approved: SAPHRIS — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for SAPHRIS (asenapine maleate) from Allergan, Inc.
-
FDA approval · 2014-09-30FDA Approved: ZYPREXA INTRAMUSCULAR — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for ZYPREXA INTRAMUSCULAR (olanzapine) by Eli Lilly and Company. The action results in changes t…
-
FDA approval · 2014-09-29FDA Approved: CLOZARIL — Supplemental Application (HLS Therapeutics (USA), Inc.)
FDA approved a supplemental application for CLOZARIL (clozapine) submitted by HLS Therapeutics (USA), Inc.
-
FDA approval · 2014-09-29FDA Approved: ABILIFY MAINTENA — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
The FDA approved a supplemental application for Abilify Maintena (aripiprazole) by Otsuka America Pharmaceutical, Inc., under NDA 202971.
-
FDA approval · 2014-09-29FDA Approved: VERSACLOZ — Supplemental Application (TruPharma LLC)
The FDA approved a supplemental application for Versacloz (clozapine) submitted by TruPharma LLC.
-
FDA approval · 2014-09-26FDA Approved: RISPERIDONE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's supplemental application for risperidone (generic), enabling the marketed generic version to …
-
FDA approval · 2014-09-25FDA Approved: RISPERIDONE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for risperidone from Zydus Lifesciences Limited.
-
FDA approval · 2014-09-25FDA Approved: RISPERIDONE — Supplemental Application (Westminster Pharmaceuticals, LLC)
FDA approved a supplemental application for risperidone by Westminster Pharmaceuticals, LLC to support a generic version of risperidone.
-
FDA approval · 2014-08-25FDA Approved: INVEGA SUSTENNA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for INVEGA SUSTENNA (paliperidone palmitate) from Janssen Pharmaceuticals, Inc., indicating a mo…
-
FDA approval · 2014-08-15FDA Approved: ABILIFY MAINTENA — Supplemental Application (Otsuka America Pharmaceutical, Inc.)
The FDA approved a supplemental application for ABILIFY MAINTENA (aripiprazole long-acting injectable) submitted by Otsuka America Pharmaceu…
-
FDA approval · 2014-08-15FDA Approved: OLANZAPINE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's generic olanzapine under an Original Application (ANDA).
-
FDA approval · 2014-08-11FDA Approved: ZYPREXA INTRAMUSCULAR — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for ZYPREXA INTRAMUSCULAR (olanzapine) submitted by Eli Lilly and Company.
-
FDA approval · 2014-07-17FDA Approved: PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for the PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE product from Mylan Pharmaceuticals Inc., in…
-
FDA approval · 2014-07-03FDA Approved: FLUPHENAZINE DECANOATE — Original Application (Endo USA, Inc.)
FDA approves a generic version of fluphenazine decanoate (long-acting injectable antipsychotic) under Original Application (ANDA) by Endo US…